Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1
In: Blood, Jg. 140 (2022-11-15), Heft Supplement 1, S. 5597-5599
Online
academicJournal
Zugriff:
Titel: |
Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1
|
---|---|
Autor/in / Beteiligte Person: | Reding, Mark T ; Mancuso, Maria Elisa ; Acharya, Suchitra ; Ahuja, Sanjay ; Álvarez-Román, Maria Teresa ; Boggio, Lisa N ; Chitlur, Meera B. ; Majluf-Cruz, Abraham Salvador ; Dunn, Amy L ; Escobar, Miguel ; Harroche, Annie ; Janbain, Maissaa ; Kessler, Craig M. ; Maes, Philip ; McGuinn, Catherine E. ; Nance, Danielle ; Nowak-Göttl, Ulrike ; Sidonio, Jr., Robert F. ; Tran, Duc Q, Jr. ; Wang, Michael ; Windyga, Jerzy ; Wang, Hongying ; Wilkinson, Thomas ; Pipe, Steven W. |
Link: | |
Zeitschrift: | Blood, Jg. 140 (2022-11-15), Heft Supplement 1, S. 5597-5599 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 0006-4971 (electronic) |
DOI: | 10.1182/blood-2022-156110 |
Sonstiges: |
|